Jason Gardner

Jason Gardner is the CEO of Ampersand Biomedicines and a CEO-Partner at Flagship Pioneering, where he leads a Boston-area biotech programming biologic medicines that act only at the site of disease. A Cambridge- and Oxford-trained scientist turned operator, he previously co-founded and ran Magenta Therapeutics through its IPO and spent years building GSK's Regenerative Medicine Unit. He is betting that the next generation of drugs will not just be potent but precise - going exactly where they are needed and nowhere else.